Harpoon Therapeutics, Inc.

NASDAQ:HARP

23.01 (USD) • At close March 11, 2024
Bedrijfsnaam Harpoon Therapeutics, Inc.
Symbool HARP
Munteenheid USD
Prijs 23.01
Beurswaarde 865,079,358
Dividendpercentage 0%
52-weken bereik 3.11 - 23.21
Industrie Biotechnology
Sector Healthcare
CEO Ms. Julie M. Eastland M.B.A.
Website https://www.harpoontx.com

An error occurred while fetching data.

Over Harpoon Therapeutics, Inc.

Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC)

Vergelijkbare Aandelen

IceCure Medical Ltd logo

IceCure Medical Ltd

ICCM

0.78 USD

Lumos Pharma, Inc. logo

Lumos Pharma, Inc.

LUMO

4.37 USD

Movano Inc. logo

Movano Inc.

MOVE

4.42 USD

Verrica Pharmaceuticals Inc. logo

Verrica Pharmaceuticals Inc.

VRCA

1.68 USD

Sientra, Inc. logo

Sientra, Inc.

SIEN

0.174 USD

Merrimack Pharmaceuticals, Inc. logo

Merrimack Pharmaceuticals, Inc.

MACK

15.145 USD

Cyteir Therapeutics, Inc. logo

Cyteir Therapeutics, Inc.

CYT

3.02 USD

Curis, Inc. logo

Curis, Inc.

CRIS

4.63 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)